U.S. safety panel says big Vytorin study can go on
NEW YORK (Reuters) - Merck & Co on Thursday said an independent data safety monitoring board has approved continuation of a big study meant to determine whether its blockbuster Vytorin cholesterol drug prevents heart attacks and stroke.
Merck said a green light for the so-called "IMPROVE-IT" study to continue was given after the panel conducted an interim analysis of safety and efficacy trends in the study, which has enrolled nearly 17,000 patients worldwide. The trial, to eventually include 18,000 patients, is expected to be completed by June 2013.
"The interim efficacy analysis was conducted by the data and safety monitoring board after the trial had reached approximately fifty percent" of the 5,250 heart attacks, strokes and other cardiovascular events to be examined during the study, Merck said in a notice on its website.
Vytorin, which Merck now owns outright after acquiring its longtime partner Schering-Plough Corp last year, is considered one of the most potent medicines available for reducing levels of "bad" LDL cholesterol.
Vytorin and the related Merck cholesterol fighter Zetia have annual revenue of almost $5 billion, but sales of the medicines have plunged in the past two years due to several trials that cast doubt on their likely effectiveness.
The IMPROVE-IT study, because of its large size, is expected to give a definitive picture of Vytorin's clinical effectiveness, and could rejuvenate sales growth if the results prove favorable.
Some analysts have said clearcut favorable data could emerge long before the study is completed, and that the data safety monitoring board might therefore halt the study early.
Merck spokesman Lee Davies on Thursday said the board will conduct another interim analysis of the study after 75 percent of pre-specified cardiovascular events occur.
Sign Up for Free Newsletters
Ask Your Doctor the RIGHT Questions!
the most from your doctor visit.
Emailed right to you!
The Ask Your Doctor email series
may contain sponsored content.
18+, US residents only please.
Get the MOST from QualityHealth
- Top Searches
- 1. Arthritis Management: Nature Heals
- 2. 5 Digestive To-Dos
- 3. Men: Should You Shave It or Leave It?
- 4. Today's Top Fitness Trends
- 5. Sugar and Osteoarthritis : The Link
- 6. Can't Afford Your Hospital Bills?
- 7. Stay Energized All Day Long
- 8. Phobias: Who Has Them and Why?
- 9. What If Your EpiPen Fails?
- 10. 5 Costly Medical Billing Mistakes
- 1. Ice Falls Can Cause Serious Injuries
- 2. Can Inactivity Act Like a Disease?
- 3. Kale Snack Recipe for Diabetics
- 4. How Running Affects Arthritis
- 5. Sugar and Your Immunity System
- 6. Do Weight Loss Supplements Work?
- 7. 5 Super Foods for Spring
- 8. The Hazards of Reusable Bags
- 9. How to Avoid Ingrown Hairs
- 10. Health Tip: Constantly Change Shoes
- 1. 4 Common Treatments for Epilepsy
- 2. What Does a Urogynecologist Do?
- 3. GERD Without Heartburn? It's Possible
- 4. Graston Technique: Can It Work on You?
- 5. Music Therapy Can Help Autism
- 6. 8 Ways to Fight MS-Related Fatigue
- 7. Can You Still Bleed After Menopause?
- 8. Be Your Own Health Care Advocate
- 9. Why Is Syphillis on the Rise?
- 10. Ideal Weight vs. Happy Weight
The material on the QualityHealth Web site is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a physician or other qualified health provider. See additional information.